Go to content
UR Home

TGF-β2 signaling in high-grade gliomas

Hau, Peter, Jachimczak, Piotr, Schlaier, Jürgen and Bogdahn, Ulrich (2011) TGF-β2 signaling in high-grade gliomas. Current pharmaceutical biotechnology 12 (12), pp. 2150-2157.

Full text not available from this repository.

at PubMed


Abstract

High-grade gliomas are the most common primary tumors in the central nervous system (CNS) in adults. Despite efforts to improve treatment by combination therapies (neurosurgery, radio- and chemotherapy), high-grade glioma patients still have a grim prognosis, indicating an urgent need for new therapeutic approaches. The molecular processes of gliomagenesis are being unraveled, and novel targeted ...

plus


Export bibliographical data



Item type:Article
Date:2011
Institutions:Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Identification Number:
ValueType
21619538PubMed ID
Classification:
NotationType
AnimalsMESH
Antineoplastic Agents/therapeutic useMESH
Brain Neoplasms/metabolismMESH
Glioma/metabolismMESH
HumansMESH
Oligodeoxyribonucleotides/therapeutic useMESH
Thionucleotides/therapeutic useMESH
Transforming Growth Factor beta2/metabolismMESH
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Unknown
Item ID:29181
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons